Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 5,284 | 7,477 | 7,396 | 6,894 | 5,918 |
| Gross Profit | 5,284 | 7,477 | 7,396 | 6,894 | 5,918 |
| Operating Expenses | 12,006 | 29,834 | 31,126 | 58,547 | 23,246 |
| Operating Income | -6,722 | -22,357 | -23,730 | -51,652 | -17,328 |
| Interest Expense | 1,493 | 2,216 | 793 | 157 | 0 |
| Other Income | -1 | 711 | 2,113 | 1,920 | 1,014 |
| Pre-tax Income | -8,216 | -23,862 | -22,411 | -49,889 | -16,313 |
| Net Income Continuous | -8,216 | -23,862 | -22,411 | -49,889 | -16,313 |
| Net Income | $-8,216 | $-23,862 | $-22,411 | $-49,889 | $-16,313 |
| EPS Basic Total Ops | -11.60 | -31.60 | -30.80 | -78.11 | -39.60 |
| EPS Basic Continuous Ops | -10.30 | -30.35 | -29.29 | -76.36 | -37.25 |
| EPS Diluted Total Ops | -11.60 | -31.60 | -30.80 | -78.11 | -39.60 |
| EPS Diluted Continuous Ops | -10.30 | -30.35 | -29.29 | -76.36 | -37.25 |
| EBITDA(a) | $-6,648 | $-22,611 | $-24,510 | $-52,224 | $-17,245 |